Uncategorized
Glaukos Announces Participation in 29th Annual ROTH Conference
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that its management is scheduled to participate in the 29th Annual ROTH Conference on Monday, March 13, 2017, at 9:30 a.m. PDT in Laguna Niguel, California. A live audio webcast for this event will be available in the Investors sec